title: Thrombosis and malignancy: a case-based review.
abstract: The association between venous thromboembolism (VTE) and malignancy is well established. Recent interest has focused on standards of care for prophylaxis, diagnosis, and treatment of malignancy-associated thrombosis. Anticoagulant management in cancer patients has unique complexities such as prolonged hospitalization, extensive surgeries, extended periods of inactivity, indwelling central venous catheters (CVC), thrombocytopenia, and pro-thrombotic medications. Here we will explore current recommendations for various specific clinical scenarios for cancer-associated thromboses. We will make evidence-based recommendations wherever possible; however, several of the scenarios here were included because pertinent high-quality evidence does not exist.
authors: Division of Hematology/Oncology, University of New Mexico Cancer Center, Albuquerque, NM 87131, USA. davgarcia@salud.unm.edu
authors: David
authors: D
authors: Garcia
authors: Dulcinea
authors: D
authors: Quintana
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000150:complications* / Q000188:drug therapy; D020246:Venous Thrombosis / Q000150:complications* / Q000188:drug therapy